Apoptosis of human gastric cancer SGC-7901 cells induced by mitomycin combined with sulindac

World Journal of Gastroenterology

Volumn 11, Issue 12, 2005, Pages 1829-1832

  Ma, Li ^a   Xie, Yong Le ^a   Yu, Yi ^a   Zhang, Qiu Ning ^a  

^a Lanzhou City University   (China)

Author keywords

Apoptosis; Gastric cancer; Induced; Mitomycin with sulindac; SGC 7901

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYCLOOXYGENASE 2; DNA FRAGMENT; MITOMYCIN; PROTEIN BCL 2; SULINDAC;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE; CELL STRUCTURE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG EXPOSURE; FLOW CYTOMETRY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LASER MICROSCOPE; MICROSCOPY; PROTEIN EXPRESSION; STOMACH CANCER; UPREGULATION;

EID: 17144371320     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i12.1829     Document Type: Article

References (24)

1. Oshima M, Murai N, Kargman S, Arguello M, Luk P, Kwong E, Taketo MM, Evans JF. Chemoprention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res 2001; 61: 1733-1740
2. Wu YL, Sun B, Zhang XJ, Wang SN, He HY, Qiao MM, Zhong J, Xu JY. Growth inhibition and apoptosis induction of Sulindac on Human gastric cancer cells. World J Gastroenterol 2001; 7: 796-800
3. Davies G, Martin LA, Sacks N, Dowsett M. Cyclooxygenase-2 (COX-2), aromatase and breast cancer: A possible role for COX-2 inhibitors in breast cancer chemoprevention. Ann Oncol 2002; 13: 669-678
4. Seno H, Oshima M, Ishikawa TO, Oshima H, Takaku K, Chiba T, Narumiya S, Taketo MM. Cyclooxygenase 2- and prostaglandin E (2) receptor EP (2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps. Cancer Res 2002; 62: 506-511
5. Fantappie O, Masini E, Sardi I, Raimondi L, Bani D, Solazzo M, Vannacci A, Mazzanti R. The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line. Hepatology 2002; 35: 843-852
6. Kakiuchi Y, Tsuji S, Tsujii M, Murata II, Kawai N, Yasumaru M, Kimura A, Komori M, Trie T, Miyoshi F, Sasaki Y, Hayashi N, Kawano S, Hori M. Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis. Cancer Res 2002; 62: 1567-1572
7. Sun B, Wu YL, Zhang XJ, Wang SN, He HY, Qiao MM, Zhang YP, Zhong J. Effects of Sulindac on growth inhibition and apoptosis induction in human gastric cancer cells. Shijie Huaren Xiaohua Zazhi 2001; 9: 997-1002
8. Mann M, Sheng H, Shao J, Williams CS, Pisacane PI, Sliwkowski M, DuBois RN. Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth. Gastroenterology 2001; 120: 1713-1719
9. Buttar NS, Wang KK, Leontovich O, Westcott JY, Pacifico RJ, Anderson MA, Krishnadath KK, Lutzke LS, Burgart LJ. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animalmodel of Barrett's esophagus. Gastroenterology 2002; 122: 1101-1112
10. Wight NJ, Gottesdiener K, Garlick NM, Atherton CT, Novak S, Gertz BJ, Calder NA, Cote J, Wong P, Dallob A, Hawkey CJ. Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production. Gastroenterology 2001; 120: 867-873
11. Zhao LQ. Celecoxib has been approved by FDA in patients with familial adenomatous polyposis. Guowai Yixue Yaoxue Fence 2000; 27: 319-320
12. Ziegler A, Luedke GH, Fabbro D, Altmann KH, Stahel RA, Zangemeister Wittke U. Induction of apoptosis in small- cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence. J Natl Cancer Inst 1997: 89: 1027-1036
13. Wang ZY, Xiao B, Shi YJ, Zhao YQ, Fan DM. Effect transfection of antisense oligonucleotides Bcl-2 on drug sensitivity in human gastric cancer cells. Shijie Huaren Xiaohua Zazhi 1999; 7 796-797
14. Ristimaki A, Honkanen N, Jankala H, Sipponen P, Harkonen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997; 57: 1276-1280
15. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cells 1995; 83: 493-501
16. Liu XH, Yao S, Kirschenbaum A, Levine AC. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res 1998; 58: 4245-4249
17. Hsueh CT, Chiu CF, Kelsen DP, Schwartz GK. Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis. Cancer Chemother Pharmacol 2000; 45: 389-396
18. Chen CJ, Sun YX, Zhou HG, Pan BR, Zheng SG, Hong XZ, Liu JH, Feng WY. bcl-2 and p53 expressions in colorectal adenoma and carcinoma. Shijie huaren Xiaohua Zazhi 1998; 6: 683-685
19. Miyashita T, Reed JC. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 1993; 81: 151-157
20. Wu GS, Wu XY, Zou SQ, Qiu FZ. Effects of cyclooxygenase-2 antisense vector on proliferation of human diolan-giocarcinoma cells. Shijie Huaren Xiaohua Zazhi 2003; 11 733-736
21. Yamamoto H, Itoh F, Fukushima H, Hinoda Y, Imai K. Overexpression of cyclooxygenase-2 protein is less frequent in gastric cancers with microsatellite instability. Int J Cancer 1999; 84 400-403
22. Yamamoto Y, Yin MJ, Lin KM, Gaynor RB. Sulindac inhibits activation of the NF-kappa B pathway. J Biol Chem 1999; 274: 27307-27314
23. Gilhooly EM, Rose DP. The association between a mutated ras gene and cyclooxygenase-2 expression in human breast cancer cell lines. Int J Oncol 1999; 15: 267-270
24. Majima M, Hayashi I, Muramatsu M, Katada J, Yamashina S, Katori M. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br J Pharmacol 2000; 130 641-649